Lupus Study Shows Promising Results Using Umbilical Cord Mesenchymal Stem Cells | Scimitar Equity Blog
Posted Jun 07 2010 9:35pm
Lupus Study Shows Promising Results Using Umbilical Cord Mesenchymal Stem Cells
June 7th, 2010 Henry McCusker
The new study shows that umbilical cord mesenchymal stem cell transplant (UC-MSCT) may improve symptoms and biochemical values in patients with severe refractory systemic lupus erythematosus (SLE).
In the 5/10 issue of Arthritis & Rheumatism, lead author and Director of Rheumatology and Immunology at Nanjing University Medical School’s Drum Tower Hospital, Dr. Lingyun Sun and colleagues reported on 16 patients with severe SLE that did not respond to standard treatments. All 16 patients received stem cell transplants. 10 patients completed at least 6 months of follow-up and 2 patients were followed for more than 2 years. There was no treatment-related mortality or other adverse event during or after UC-MSCT.
Dr. Sun said, “The disease activity among patients was significantly improved during the first 3 months of follow-up.” After nearly two years, most patients show clinical remission with no adverse events detected to date or treatment-related mortality.”